文献速递腹部技术与安全US

全氟丁烷增强超声鉴别肝细胞癌与非肝细胞恶性肿瘤或良性病变:不同图像采集方法的比较

Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods.
PubMed 文献 · Ultrasound Med Biol · 2023-07-24

前瞻性研究纳入69例拟行活检或射频消融的肝脏实性病变患者(病变>1 cm),比较三种图像采集方法对全氟丁烷增强超声鉴别肝细胞癌的诊断效能。排除7例技术失败后分析62例(良性7例、非肝细胞恶性肿瘤37例、肝细胞癌18例),方法C(注射后5分钟内采集加库普弗期)灵敏度最高(75.9%)、准确率最高(87.1%),但差异均未达统计学显著。

要点

  • 全氟丁烷增强超声诊断肝细胞癌时,增加库普弗期采集(方法C)灵敏度75.9%、准确率87.1%,均为三种方法中最高。
  • 三种采集方法诊断肝细胞癌的灵敏度差异(p=0.12)、特异度差异(p=0.28)和准确率差异(p=0.24)均未达统计学显著。
  • 本研究样本中非肝细胞恶性肿瘤(37例)多于肝细胞癌(18例),判读时需注意病变构成比。

核心结论

  • 注射对比剂后5分钟内采集并附加库普弗期,可能在全氟丁烷增强超声诊断肝细胞癌时获得较高准确率和灵敏度,且不损失特异度。

研究设计与样本

  • 前瞻性研究,2020年9月至2021年3月纳入69例拟行活检或射频消融的肝脏实性病变(>1 cm)患者,排除7例技术失败后分析62例,由三名盲法放射科医生阅片。

诊断标准与关键数值

  • 方法A(注射后5分钟内采集)诊断肝细胞癌灵敏度68.5%。
  • 方法B(注射后1分钟内采集加库普弗期)诊断肝细胞癌灵敏度72.2%。
  • 方法C(注射后5分钟内采集加库普弗期)诊断肝细胞癌灵敏度75.9%。
  • 三种方法诊断肝细胞癌的汇总特异度差异无统计学显著(p=0.28)。
  • 方法C诊断肝细胞癌准确率最高(87.1%),但差异未达统计学显著(p=0.24)。

局限性

  • 三种采集方法诊断肝细胞癌的灵敏度差异未达统计学显著(p=0.12)。
  • 三种采集方法诊断肝细胞癌的准确率差异未达统计学显著(p=0.24)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of the work described here was to evaluate the diagnostic performance of perfluorobutane (PFB)-enhanced ultrasound in differentiating hepatocellular carcinoma (HCC) from non-HCC malignancies and other benign lesions using different acquisition methods.

METHODS: This prospective study included 69 patients with solid liver lesions larger than 1 cm who were scheduled for biopsy or radiofrequency ablation between September 2020 and March 2021. Lesion diagnosis was designated by three blinded radiologists after reviewing three different sets of acquired images selected according to the following presumed acquisition methods: (i) method A, acquisition up to 5 min after contrast injection; (ii) method B, acquisition up to 1 min after contrast injection with additional Kupffer phase; and (iii) method C, acquisition up to 5 min after contrast injection with additional Kupffer phase.

RESULTS: After excluding 7 technical failures, 62 patients with liver lesions (mean size: 24.2 ± 14.8 mm), which consisted of 7 benign lesions, 37 non-HCC malignancies and 18 HCCs. For the HCC diagnosis, method C had the highest sensitivity (75.9%), followed by method B (72.2%) and method A (68.5%), but failed to exhibit statistical significance (p = 0.12). There was no significant difference with respect to the pooled specificity between the three methods (p = 0.28). Diagnostic accuracy was the highest with method C (87.1%) but failed to exhibit statistical significance (p = 0.24).

CONCLUSION: Image acquisition up to 5 min after contrast injection with additional Kupffer phase could potentially result in high accuracy and sensitivity without loss of specificity in diagnosing HCC with PFB-enhanced ultrasound.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Han S, Kim SW, Park S, et al. Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods. Ultrasound Med Biol. 2023. PMID: 37495497. doi:10.1016/j.ultrasmedbio.2023.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。